Centocor Loses Bid To Dismiss Remicade Suit

Law360, New York (November 8, 2010, 6:29 PM EST) -- Johnson & Johnson Inc. subsidiary Centocor Ortho Biotech Inc. has failed to persuade a federal judge to throw out a suit a patient filed over a warning label developed for Remicade.

Judge James G. Carr of the U.S. District Court for the Northern District of Ohio ruled that Centocor had not, as a matter of law, warned patient Anthony DeGidio that he might contract a noninfectious lung disease if he used Remicade.

The warning did mention that Remicade might cause an infectious lung disease, but had...
To view the full article, register now.